These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 12872360

  • 21. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S.
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [Abstract] [Full Text] [Related]

  • 22. MR-guided intervention in women at high hereditary risk of breast cancer due to both family and personal history of breast cancer.
    Viehweg P, Bernerth T, Heinig A, Kiechle M, Buchmann J, Koelbl H, Laniado M, Helen Heywang-Köbrunner S.
    Breast J; 2006 Dec; 12(6):549-58. PubMed ID: 17238985
    [Abstract] [Full Text] [Related]

  • 23. Outcome of initially only magnetic resonance mammography-detected findings with and without correlate at second-look sonography: distribution according to patient history of breast cancer and lesion size.
    Linda A, Zuiani C, Londero V, Bazzocchi M.
    Breast; 2008 Feb; 17(1):51-7. PubMed ID: 17709249
    [Abstract] [Full Text] [Related]

  • 24. The development of interval breast malignancies in patients with BRCA mutations.
    Komenaka IK, Ditkoff BA, Joseph KA, Russo D, Gorroochurn P, Ward M, Horowitz E, El-Tamer MB, Schnabel FR.
    Cancer; 2004 May 15; 100(10):2079-83. PubMed ID: 15139048
    [Abstract] [Full Text] [Related]

  • 25. Magnetic resonance-guided, vacuum-assisted breast biopsy: results from a European multicenter study of 538 lesions.
    Perlet C, Heywang-Kobrunner SH, Heinig A, Sittek H, Casselman J, Anderson I, Taourel P.
    Cancer; 2006 Mar 01; 106(5):982-90. PubMed ID: 16456807
    [Abstract] [Full Text] [Related]

  • 26. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
    Kriege M, Brekelmans CT, Boetes C, Muller SH, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Rutgers EJ, de Koning HJ, Klijn JG, Dutch MRI Screening (MRISC) Study Group.
    Cancer; 2006 Jun 01; 106(11):2318-26. PubMed ID: 16615112
    [Abstract] [Full Text] [Related]

  • 27. Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer.
    Riedl CC, Ponhold L, Flöry D, Weber M, Kroiss R, Wagner T, Fuchsjäger M, Helbich TH.
    Clin Cancer Res; 2007 Oct 15; 13(20):6144-52. PubMed ID: 17947480
    [Abstract] [Full Text] [Related]

  • 28. Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound.
    Vassiou K, Kanavou T, Vlychou M, Poultsidi A, Athanasiou E, Arvanitis DL, Fezoulidis IV.
    Eur J Radiol; 2009 Apr 15; 70(1):69-76. PubMed ID: 18295425
    [Abstract] [Full Text] [Related]

  • 29. [The "EVA" Trial: Evaluation of the Efficacy of Diagnostic Methods (Mammography, Ultrasound, MRI) in the secondary and tertiary prevention of familial breast cancer. Preliminary results after the first half of the study period].
    Kuhl CK, Schrading S, Weigel S, Nüssle-Kügele K, Sittek H, Arand B, Morakkabati N, Leutner C, Tombach B, Nordhoff D, Perlet C, Rieber A, Heindel W, Brambs HJ, Schild H.
    Rofo; 2005 Jun 15; 177(6):818-27. PubMed ID: 15902631
    [Abstract] [Full Text] [Related]

  • 30. Probably benign lesions detected on breast MR imaging.
    Eby PR, DeMartini WB, Gutierrez RL, Lehman CD.
    Magn Reson Imaging Clin N Am; 2010 May 15; 18(2):309-21, x. PubMed ID: 20494314
    [Abstract] [Full Text] [Related]

  • 31. Imaging of breast cancer diagnosed and treated with chemotherapy during pregnancy.
    Yang WT, Dryden MJ, Gwyn K, Whitman GJ, Theriault R.
    Radiology; 2006 Apr 15; 239(1):52-60. PubMed ID: 16484353
    [Abstract] [Full Text] [Related]

  • 32. Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ.
    Friedlander LC, Roth SO, Gavenonis SC.
    Radiology; 2011 Nov 15; 261(2):421-7. PubMed ID: 21900618
    [Abstract] [Full Text] [Related]

  • 33. Follow-up frequency and compliance in women with probably benign findings on breast magnetic resonance imaging.
    Marshall AL, Domchek SM, Weinstein SP.
    Acad Radiol; 2012 Apr 15; 19(4):406-11. PubMed ID: 22227041
    [Abstract] [Full Text] [Related]

  • 34. Unilateral breast cancer: screening of contralateral breast by using preoperative MR imaging reduces incidence of metachronous cancer.
    Kim JY, Cho N, Koo HR, Yi A, Kim WH, Lee SH, Chang JM, Han W, Moon HG, Im SA, Noh DY, Moon WK.
    Radiology; 2013 Apr 15; 267(1):57-66. PubMed ID: 23329656
    [Abstract] [Full Text] [Related]

  • 35. Impact of breast MR in non-screening Australian clinical practice: audit data from a single-reader single-centre site.
    El-Barhoun EN, Pitman AG.
    J Med Imaging Radiat Oncol; 2011 Oct 15; 55(5):461-73. PubMed ID: 22008164
    [Abstract] [Full Text] [Related]

  • 36. Short-term follow-up of palpable breast lesions with benign imaging features: evaluation of 375 lesions in 320 women.
    Harvey JA, Nicholson BT, Lorusso AP, Cohen MA, Bovbjerg VE.
    AJR Am J Roentgenol; 2009 Dec 15; 193(6):1723-30. PubMed ID: 19933671
    [Abstract] [Full Text] [Related]

  • 37. Differential diagnosis of breast lesions 5 mm or less: is there a role for magnetic resonance imaging?
    Dietzel M, Baltzer PA, Vag T, Gröschel T, Gajda M, Camara O, Kaiser WA.
    J Comput Assist Tomogr; 2010 Dec 15; 34(3):456-64. PubMed ID: 20498554
    [Abstract] [Full Text] [Related]

  • 38. The utility of breast MRI as a problem-solving tool.
    Yau EJ, Gutierrez RL, DeMartini WB, Eby PR, Peacock S, Lehman CD.
    Breast J; 2011 Dec 15; 17(3):273-80. PubMed ID: 21477168
    [Abstract] [Full Text] [Related]

  • 39. Management of probably benign breast lesions.
    Sickles EA.
    Radiol Clin North Am; 1995 Nov 15; 33(6):1123-30. PubMed ID: 7480660
    [Abstract] [Full Text] [Related]

  • 40. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results.
    Kuhl CK, Schmutzler RK, Leutner CC, Kempe A, Wardelmann E, Hocke A, Maringa M, Pfeifer U, Krebs D, Schild HH.
    Radiology; 2000 Apr 15; 215(1):267-79. PubMed ID: 10751498
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.